The Story Of Our Firm | En Français | En Español
FONT SIZE: A A A A A

Previous Investigations Other Litigations Cytotec Research Center

Major Label Changes

in this section: Breaking News | Uses & Precautions | Major Label Changes | Letters & Publications


Bookmark This Page Print This Page Email This Page

Cytotec Labeling: Major Changes

Weitz and Luxenberg is no longer accepting Cytotec cases.

If you or a loved one has been harmed by off-label use of Cytotec, fill out this simple form today for a FREE case evaluation.

  • Revises the contraindication and precaution that Cytotec should not be used in women who are pregnant by stating that the contraindication is for pregnant women who are using Cytotec to reduce the risk of non-steroidal anti-inflammatory drug (NSAID)-induced stomach ulcers.

    • Rationale: The drug has a recognized use by obstetricians and gynecologists (OB-Gyns) to induce labor, delivery, and is part of the FDA approved regimen for use with mifepristone to induce abortion in pregnancies of 49 days or less. The contraindication now refers to the drug’s approved indication, for reducing the risk of NSAID-induced gastric ulcers.

  • Creates a new labor and delivery section of the labeling and provides safety information related to those uses. Rationale: 21 CFR 201.57(f)(7) requires labeling to include drug effect information if a drug has a recognized use during labor or delivery, whether or not the use is stated in the indications section of the labeling.
  • Provides new information that uterine rupture, an adverse event reported with Cytotec, is associated with risk factors, such as later trimester pregnancies, higher doses of the drug, including the manufactured 100 mcg tablets, prior Cesarean delivery or uterine surgery, and having had five or more previous pregnancies.

    • Rationale: Risk factors allow physicians to identify patients who may be at greater risk for these adverse events. This information may guide safer use of the drug.

5/21/02 www.FDA.gov


see also:

Breaking News Cytotec Misoprostol Resources: Cytotec Breaking News
Cytotec Misoprostol Information: Cytotec (Misoprostol) Breaking News

Major Label Changes FREE information about Cytotec Misoprostol - Major Label Changes from FDA
Cytotec Major Label Changes: from the FDA

News & Warnings Cytotec Lawsuits FREE Research Resources
ree information on Cytotec and Cytotec lawsuits.

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question
Free Legal Review
Name:
Phone:
Email:
Case Description:
$423 million settlement— MTBE suit involving the contamination of 153 public water systems nationally

$16.5 million verdict — Asbestos case involving exposure from dental tape

$1.4 million settlement — Accident involving woman struck down by ambulance

$1.5 million settlement — for 47-year-old construction worker who fell off elevated train tracks

$6 million settlement — Pediatric malpractice involving infant who suffered brain damage at birth

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims



Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.